Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Critical reviews in biochemistry and molecular biology

• Publication date

  2011-07-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/10409238.2011.597737PMID 21787121PMCID PMC3144498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support

  2016cited by this paper
• Combined anticancer effects of sphingosine kinase inhibitors and sorafenib

  2011cited by this paper
• Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer

  2011cited by this paper
• A Role of Sphingosine Kinase 1 in Head and Neck Carcinogenesis

  2011cited by this paper
• Sphingosine kinase 1 is a relevant molecular target in gastric cancer

  2011cited by this paper
• Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration

  2011cited by this paper
• Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition

  2011cited by this paper
• A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors

  2011cited by this paper
• Altered sphingolipid metabolism in human endometrial cancer.

  2010cited by this paper
• Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

  2010cited by this paper
• Role of sphingosine kinase‐1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro

  2010cited by this paper
• Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.

  2010influential reference
• C‐Myc is a Nrf2‐interacting protein that negatively regulates phase II genes through their electrophile responsive elements

  2010cited by this paper
• Mammalian ceramide synthases

  2010cited by this paper
• Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens.

  2010cited by this paper
• Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.

  2010cited by this paper
• Sphingosine kinase 1 inhibition sensitizes hormone‐resistant prostate cancer to docetaxel

  2009cited by this paper
• Role for sphingosine kinase 1 in colon carcinogenesis

  2009cited by this paper
• Ceramide induces endothelial cell senescence

  2009cited by this paper
• Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

  2009cited by this paper
• Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients

  2009cited by this paper
• S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.

  2009cited by this paper
• Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.

  2009cited by this paper
• Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.

  2009cited by this paper
• Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway.

  2009cited by this paper
• Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

  2009cited by this paper
• Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy.

  2009cited by this paper
• Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models

  2008cited by this paper
• Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

  2008cited by this paper
• KLF2 Transcription Factor Modulates Blood Vessel Maturation through Smooth Muscle Cell Migration*

  2008cited by this paper
• Targeting SphK1 as a new strategy against cancer.

  2008cited by this paper
• Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells.

  2008cited by this paper
• A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

  2008cited by this paper
• Principles of bioactive lipid signalling: lessons from sphingolipids

  2008cited by this paper
• v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins

  2008cited by this paper
• Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

  2008cited by this paper
• Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase 3 in colon cancer cells

  2008cited by this paper
• Sphingosine Kinase 1 Is Up-regulated during Hypoxia in U87MG Glioma Cells

  2008cited by this paper
• Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas

  2007cited by this paper
• Sphingosine kinase-1 – a potential therapeutic target in cancer

  2007cited by this paper
• Recycling of Sphingosine Is Regulated by the Concerted Actions of Sphingosine-1-phosphate Phosphohydrolase 1 and Sphingosine Kinase 2*

  2007cited by this paper
• Shift in sphingolipid metabolism leads to an accumulation of ceramide in senescence.

  2006cited by this paper
• Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes

  2006cited by this paper
• Kruppel-like factor 2 regulates thymocyte and T-cell migration

  2006cited by this paper
• Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1

  2006cited by this paper
• Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

  2006cited by this paper
• Loss of sphingosine kinase‐1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis

  2006cited by this paper
• Sphingosine kinase‐1 is cleaved by cathepsin B in vitro: Identification of the initial cleavage sites for the protease

  2006cited by this paper
• Lymphangiogenesis in vitro

  2006cited by this paper
• Intracellular Role for Sphingosine Kinase 1 in Intestinal Adenoma Cell Proliferation

  2006cited by this paper
• Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer

  2006cited by this paper
• Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling

  2005cited by this paper
• Essential Role for Sphingosine Kinases in Neural and Vascular Development

  2005cited by this paper
• Sphingosine Kinase Regulates the Sensitivity of Dictyostelium discoideum Cells to the Anticancer Drug Cisplatin

  2005cited by this paper
• Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.

  2005influential reference
• Tumor Necrosis Factor Induces the Loss of Sphingosine Kinase-1 by a Cathepsin B-dependent Mechanism*

  2005cited by this paper
• Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

  2005cited by this paper
• SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism*

  2005cited by this paper
• Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue

  2005cited by this paper
• Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines

  2005influential reference
• The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis*

  2004cited by this paper
• Down-regulation of Sphingosine Kinase-1 by DNA Damage

  2004cited by this paper
• Overexpression of Sphingosine-1-Phosphate Lyase or Inhibition of Sphingosine Kinase in Dictyostelium discoideum Results in a Selective Increase in Sensitivity to Platinum-Based Chemotherapy Drugs

  2004cited by this paper
• Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference.

  2004cited by this paper
• G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation.

  2003cited by this paper
• Discovery and evaluation of inhibitors of human sphingosine kinase.

  2003cited by this paper
• Sphingosine kinase transmits estrogen signaling in human breast cancer cells.

  2003cited by this paper
• Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis*

  2003cited by this paper
• Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.

  2002cited by this paper
• Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells

  2002cited by this paper
• Enzymes of sphingolipid metabolism: from modular to integrative signaling.

  2001influential reference
• Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

  2001cited by this paper
• Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

  2000cited by this paper
• An oncogenic role of sphingosine kinase.

  2000cited by this paper
• Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival

  1999cited by this paper
• Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells.

  1999cited by this paper
• Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

  1998cited by this paper
• Selectivity of sphingosine-induced apoptosis. Lack of activity of DL-erythyro-dihydrosphingosine.

  1998cited by this paper
• N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide.

  1998cited by this paper
• Sphingosine‐1‐Phosphate in Cell Growth and Cell Death a

  1998cited by this paper
• Quantitative rt-PCR.

  1998cited by this paper
• Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

  1996cited by this paper
• Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism

  1995cited by this paper
• Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents.

  1995cited by this paper
• Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens

  1993influential reference

• SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway

  2025cites this paper
• Sphingolipid modulation and anti-tumor activity of Jaspine B in HepG2 bearing mice

  2025cites this paper
• Organocatalyst as a synthetic gadget for pharmaceutically potent molecules

  2024cites this paper
• Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.

  2024cites this paper
• Sphingolipids: From structural components to signaling hubs.

  2023cites this paper
• The next decade of SET: from an oncoprotein to beyond

  2023cites this paper
• Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion

  2023cites this paper
• Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis

  2022cites this paper
• 1-Deoxysphinganine initiates adaptive responses to serine and glycine starvation in cancer cells via proteolysis of sphingosine kinase

  2021cites this paper
• Modulation of DNA Damage Response by Sphingolipid Signaling: An Interplay that Shapes Cell Fate

  2020cites this paper
• Implication of Integrated in Silico Docking and Moma Simulation for the Development of Curcuminoids as Sphingosine Kinase 1 (SK1) Inhibitors for Cancer Treatment

  2020cites this paper
• Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

  2020cites this paper
• Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

  2020cites this paper
• Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma

  2020cites this paper
• Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks

  2020cites this paper
• Contributions of MS metabolomics to gilthead sea bream (Sparus aurata) nutrition. Serum fingerprinting of fish fed low fish meal and fish oil diets

  2019cites this paper
• Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.

  2019cites this paper
• Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer

  2019cites this paper
• Antitumor effect of the combination of exogenous sphingosine-1-phosphate(S1P), S1P receptor 1(S1PR1) antibody and carboplatin against human breast cancer cells

  2018influential citation
• Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors.

  2018cites this paper
• Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma

  2017cites this paper
• An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.

  2017cites this paper
• On the role of bioactive sphingolipids and their metabolizing enzymes in cancer

  2017cites this paper
• Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph node metastasis in esophageal squamous cell carcinoma

  2017cites this paper
• Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget

  2017cites this paper
• Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.

  2017cites this paper
• Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines

  2017cites this paper
• Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast.

  2017cites this paper
• Sphingosine kinase inhibitors: a review of patent literature (2006-2015)

  2016cites this paper
• Ceramide and sphingosine-1-phosphate in cancer, two faces of the sphinx

  2015cites this paper
• Sphingolipids in the DNA damage response.

  2015cites this paper
• ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer

  2015cites this paper
• Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

  2015cites this paper
• Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

  2014cites this paper
• Fluorescent lipids as probes for sphingosine kinase activity by capillary electrophoresis.

  2013cites this paper
• Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.

  2013cites this paper
• Structure guided design of a series of sphingosine kinase (SphK) inhibitors.

  2013cites this paper
• Sphingosine kinase 1 in cancer.

  2013cites this paper
• Roles, regulation and inhibitors of sphingosine kinase 2

  2013cites this paper
• Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.

  2013cites this paper
• Sphingosine‐1‐phosphate receptor 2

  2013cites this paper
• Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent

  2013cites this paper
• Protumor and antitumor functions of neutrophil granulocytes

  2013cites this paper
• Sphingosine Kinase 1 Serves as a Pro-Viral Factor by Regulating Viral RNA Synthesis and Nuclear Export of Viral Ribonucleoprotein Complex upon Influenza Virus Infection

  2013cites this paper
• Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells.

  2012cites this paper
• Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism.

  2012cites this paper
• Sphingosine 1-phosphate and human ether-a 0 -go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells

  2012cites this paper